Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

E. Franceschi, Roberta Depenni, Alexandro Paccapelo, Mario Ermani, Marina Faedi, Carmelo Sturiale, Maria Michiara, Franco Servadei, Giacomo Pavesi, B. Urbini, A. Pisanello, G. Crisi, Agostino Baruzzi, Agostino Baruzzi, F. Albani, R. Michelucci, M. Cavallo, A. Tosoni, M. Cavallo, A. ValentiniA. Pisanello, S. Testoni, R. Agati, A. Bacci, E. Baldin, E. Barbieri, F. Bisulli, V. Carelli, M. Crisci, D. de Biase, C. Franceschi, M. Leonardi, G. Marucci, L. Morandi, B. Mostacci, G. Palandri, E. Pasini, P. Riguzzi, P. Tinuper, G. Gentili, Marina Faedi, F. Zumaglini, A. Amadori, F. Bertolini, G. Pinna, M. Ragazzi, R. Rizzi, S. Seraceni, C. Giorgi, E. Montanari, The Perno Study Group

Research output: Contribution to journalArticlepeer-review

Abstract

The members of the PERNO Study Group were not individually captured in the metadata of the original publication. They are included in the metadata of this publication.

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalJournal of Neuro-Oncology
DOIs
Publication statusAccepted/In press - Nov 9 2017

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study'. Together they form a unique fingerprint.

Cite this